Delek US Holdings CFO Executes Routine 10(b)(5)(1) Sale of 20,000 Shares, No Sign of Strategic Shift【】
Delek US insider sales show routine 10(b)(5)(1) moves, minimal dilution, and no sign of distress – a potential early hint of a short‑term rally.
3 minutes to read









